Moraxella bovis protease vaccine

Details Moraxella bovis protease vaccine Moraxella bovis protease vaccine

1983-12-12

1987-06-23

Wiseman, Thomas G.

Drug, bio-affecting and body treating compositions

Lymphokine

424 92, 435220, A61K 3748, A61K 3900, C12N 952

Patent

active

046751769

ABSTRACT:
Protease produced by Moraxella bovis can be used as an immunoprophylactic agent for protection against infection by M. bovis.

REFERENCES:
patent: 3197373 (1965-07-01), Jackson
patent: 3401219 (1968-09-01), Zeissig
patent: 3853990 (1974-12-01), Madigan et al.
patent: 4254098 (1981-03-01), Graham, Jr. et al.
Frank, Sandra K. and Jay D. Gerber, "Hydrolytic Enzymes of Moraxella bovis," J. of Clin. Imm., Feb. 1981, pp. 269-271.
Hughes, D. E., et al., Am. Journal Vet. Res., vol. 38, No. 11 (Nov. 1977) pp. 1905-1907.
Sandhu, T. S. and Franklin H. White, "Extracellular Antigens of Moraxella bovis," Am. Journal of Vet. Res., vol. 37, pp. 1119-1122, Sep. 1976.
Windholz, et al., (Ed.) The Merck Index (10th ed.) 1983, p. 1126 (#7721).
Van Bijsterveld, O. P.; "Bacterial Proteases in Moraxella Angular Conjunctivitis," Amer. J. of Ophthalmology, vol. 72, No. 1, (1971); pp. 181-184.
Frank et al.; "Hydrolytic Enzymes of Moraxella bovis"; Chemical Abstracts, vol. 94, No. 15, Apr. 13, 1981; p. 349, Abstract No. 117523e.
Pugh et al., Can. J. Comp. Med. 37:70-78 (1973).
PILIGUARD.TM. product bulletin.

Affiliated with

Also associated with

Rating

Moraxella bovis protease vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Moraxella bovis protease vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Moraxella bovis protease vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-720222